JP2008504304A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008504304A5 JP2008504304A5 JP2007518382A JP2007518382A JP2008504304A5 JP 2008504304 A5 JP2008504304 A5 JP 2008504304A5 JP 2007518382 A JP2007518382 A JP 2007518382A JP 2007518382 A JP2007518382 A JP 2007518382A JP 2008504304 A5 JP2008504304 A5 JP 2008504304A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- compound
- heteroalkyl
- membered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C*(*)CC(CC1)CC2=C1N=C(C(*)N(N*)I*)N(*)C2=O Chemical compound C*(*)CC(CC1)CC2=C1N=C(C(*)N(N*)I*)N(*)C2=O 0.000 description 1
- FKQYECMKLWYTCQ-UHFFFAOYSA-N CC(Cc1ccc(C(F)(F)F)c(F)c1)=O Chemical compound CC(Cc1ccc(C(F)(F)F)c(F)c1)=O FKQYECMKLWYTCQ-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58382304P | 2004-06-28 | 2004-06-28 | |
| PCT/US2005/023275 WO2006004925A1 (en) | 2004-06-28 | 2005-06-28 | Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008504304A JP2008504304A (ja) | 2008-02-14 |
| JP2008504304A5 true JP2008504304A5 (enExample) | 2008-08-14 |
Family
ID=34982539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007518382A Pending JP2008504304A (ja) | 2004-06-28 | 2005-06-28 | テトラヒドロキナゾリン−４（３ｈ）−オン関連、及びテトラヒドロピリド［２，３−ｄ］ピリミジン−４（３ｈ）−オン関連化合物、組成物、及びそれらの使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7375102B2 (enExample) |
| EP (1) | EP1765818A1 (enExample) |
| JP (1) | JP2008504304A (enExample) |
| AU (1) | AU2005260630A1 (enExample) |
| CA (1) | CA2572084A1 (enExample) |
| MX (1) | MX2007000044A (enExample) |
| WO (1) | WO2006004925A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6858615B2 (en) | 2002-02-19 | 2005-02-22 | Parion Sciences, Inc. | Phenyl guanidine sodium channel blockers |
| US7939538B2 (en) * | 2004-06-28 | 2011-05-10 | Amgen Inc. | Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases |
| TW200714610A (en) * | 2005-02-16 | 2007-04-16 | Univ Maryland | CXCR3 is a gliadin receptor |
| US20110052612A1 (en) * | 2005-05-31 | 2011-03-03 | Ono Pharmaceutical Co., Ltd. | Spiropiperidine compound and medicinal use thereof |
| JP2008546843A (ja) * | 2005-06-27 | 2008-12-25 | アムゲン インコーポレイティッド | 抗炎症性アリールニトリル化合物 |
| WO2009094168A1 (en) * | 2008-01-22 | 2009-07-30 | Amgen Inc. | Cxcr3 antagonists |
| US8741259B2 (en) * | 2008-10-20 | 2014-06-03 | Marvin C. Gershengorn | Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists |
| EP2563777A4 (en) | 2010-04-08 | 2013-09-04 | Us Health | INVERSE AGONISTS AND NEUTRAL AGONISTS FOR THE TSH RECEPTOR |
| PL2723176T3 (pl) | 2011-06-27 | 2018-01-31 | Parion Sciences Inc | Chemicznie i metabolicznie stabilny dipeptyd o silnej aktywności blokera kanału sodowego |
| AR086745A1 (es) | 2011-06-27 | 2014-01-22 | Parion Sciences Inc | 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida |
| EP2731942B1 (en) | 2011-07-13 | 2015-09-23 | Novartis AG | Novel 2-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitors |
| EP2731951B1 (en) | 2011-07-13 | 2015-08-19 | Novartis AG | 4-oxo-3,5,7,8-tetrahydro-4h-pyrano {4,3-d} pyrminidinyl compounds for use as tankyrase inhibitors |
| KR20140051944A (ko) | 2011-07-13 | 2014-05-02 | 노파르티스 아게 | 탄키라제 억제제로서 사용하기 위한 4-피페리디닐 화합물 |
| US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| CA2872029A1 (en) | 2012-05-29 | 2013-12-05 | Parion Sciences, Inc. | Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases |
| CA2896686A1 (en) | 2012-12-17 | 2014-06-26 | Parion Sciences, Inc. | 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds |
| PE20151054A1 (es) | 2012-12-17 | 2015-08-07 | Parion Sciences Inc | Derivados de cloro-pirazin carboxamida con actividad bloqueadora sobre los canales de sodio epiteliales |
| MX2015007797A (es) | 2012-12-17 | 2015-10-05 | Parion Sciences Inc | Compuestos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil) carbamimidoil) pirazin-2-carboxamida. |
| PE20160685A1 (es) | 2013-10-04 | 2016-07-23 | Infinity Pharmaceuticals Inc | Compuestos heterociclicos y usos de los mismos |
| US9751888B2 (en) | 2013-10-04 | 2017-09-05 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| US9102633B2 (en) | 2013-12-13 | 2015-08-11 | Parion Sciences, Inc. | Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds |
| SG10201808053XA (en) | 2014-03-19 | 2018-10-30 | Infinity Pharmaceuticals Inc | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders |
| US9708348B2 (en) | 2014-10-03 | 2017-07-18 | Infinity Pharmaceuticals, Inc. | Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof |
| US10160761B2 (en) | 2015-09-14 | 2018-12-25 | Infinity Pharmaceuticals, Inc. | Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same |
| WO2017161116A1 (en) | 2016-03-17 | 2017-09-21 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors |
| US10919914B2 (en) | 2016-06-08 | 2021-02-16 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| WO2019054476A1 (ja) * | 2017-09-14 | 2019-03-21 | 住友金属鉱山株式会社 | 近赤外線吸収繊維およびこれを用いた繊維製品、並びにそれらの製造方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0481614A1 (en) | 1990-10-01 | 1992-04-22 | Merck & Co. Inc. | Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists |
| US5256667A (en) | 1991-09-25 | 1993-10-26 | Merck & Co., Inc. | Quinazolinones and pyridopyrimidinones |
| US5202322A (en) | 1991-09-25 | 1993-04-13 | Merck & Co., Inc. | Quinazolinone and pyridopyrimidine a-II antagonists |
| US5756502A (en) | 1994-08-08 | 1998-05-26 | Warner-Lambert Company | Quinazolinone derivatives as cholyecystokinin (CCK) ligands |
| US5719144A (en) | 1995-02-22 | 1998-02-17 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| US5908930A (en) | 1995-03-15 | 1999-06-01 | Pfizer Inc. | 5,10-dihydropyrimdo 4,5-b!quinolin-4(1H)-one tyrosine kinase inhibitors |
| US6140064A (en) | 1996-09-10 | 2000-10-31 | Theodor-Kocher Institute | Method of detecting or identifying ligands, inhibitors or promoters of CXC chemokine receptor 3 |
| FR2778662B1 (fr) | 1998-05-12 | 2000-06-16 | Adir | Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| JP4831906B2 (ja) * | 1999-08-27 | 2011-12-07 | ケモセントリックス， インコーポレイテッド | Ｃｘｃｒ３機能を調節するための複素環式化合物および方法 |
| ATE286033T1 (de) | 1999-09-16 | 2005-01-15 | Curis Inc | Vermittler von igel signalwegen, deren zusammenstellungen und verwendungen |
| ES2263501T3 (es) | 1999-10-27 | 2006-12-16 | Cytokinetics, Inc. | Procedimiento y composiciones que utilizan quinazolinonas. |
| US6545004B1 (en) | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
| GB2359551A (en) | 2000-02-23 | 2001-08-29 | Astrazeneca Uk Ltd | Pharmaceutically active pyrimidine derivatives |
| NZ526622A (en) | 2000-12-11 | 2006-07-28 | Amgen Sf Llc | CXCR3 antagonists |
| US6794379B2 (en) | 2001-06-06 | 2004-09-21 | Tularik Inc. | CXCR3 antagonists |
| EP1521746B1 (en) | 2002-03-07 | 2011-04-27 | X-Ceptor Therapeutics, Inc. | Quinazolinone modulators of nuclear receptors |
| EP1503993A4 (en) | 2002-05-09 | 2006-05-03 | Cytokinetics Inc | COMPOUNDS, METHODS AND COMPOSITIONS |
| US20040242498A1 (en) | 2003-02-27 | 2004-12-02 | Collins Tassie L. | CXCR3 antagonists |
| US7183413B2 (en) | 2003-04-11 | 2007-02-27 | Taigen Biotechnology | Aminoquinoline compounds |
-
2005
- 2005-06-27 US US11/168,006 patent/US7375102B2/en not_active Expired - Fee Related
- 2005-06-28 EP EP05768335A patent/EP1765818A1/en not_active Withdrawn
- 2005-06-28 JP JP2007518382A patent/JP2008504304A/ja active Pending
- 2005-06-28 CA CA002572084A patent/CA2572084A1/en not_active Abandoned
- 2005-06-28 MX MX2007000044A patent/MX2007000044A/es active IP Right Grant
- 2005-06-28 WO PCT/US2005/023275 patent/WO2006004925A1/en not_active Ceased
- 2005-06-28 AU AU2005260630A patent/AU2005260630A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008504301A5 (enExample) | ||
| KR102034618B1 (ko) | Dna 알킬화제 | |
| JP2024534526A (ja) | ピリジン系誘導体及びその使用 | |
| ES2280768T3 (es) | Inhibidores de histona desacetilasa. | |
| KR102093608B1 (ko) | 이미다조피리딘 화합물 | |
| JP2017511357A5 (enExample) | ||
| JP2009525287A (ja) | ウイルスポリメラーゼインヒビター | |
| JP2013523803A5 (enExample) | ||
| WO2003064410A1 (en) | Novel 1,2,4-triazole compound | |
| JP2011502956A5 (enExample) | ||
| JP2010525023A5 (enExample) | ||
| CN101426766A (zh) | 用作mek抑制剂的新颖的杂芳基取代的芳基氨基吡啶衍生物 | |
| JP2007524696A5 (enExample) | ||
| JP2016500107A5 (ja) | グルタミナーゼ阻害剤およびその使用方法 | |
| RU2008133383A (ru) | Производные гидантоина для лечения воспалительных заболеваний | |
| JP2013507355A (ja) | キサンチンオキシダーゼ阻害剤として効果的な新規化合物、その製造方法及びそれを含有する医薬組成物 | |
| JP2007500719A5 (enExample) | ||
| AU2002238855B2 (en) | N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same | |
| KR20110133049A (ko) | 항암 약물로서의 니코틴아미드 유도체, 그의 제조법 및 그의 치료 용도 | |
| AU2007270083A1 (en) | New pyridine analogues | |
| JP2013544854A5 (enExample) | ||
| JP2008509955A5 (enExample) | ||
| JP2022522312A (ja) | ピロール化合物 | |
| JP2020518571A5 (enExample) | ||
| JP2020512400A5 (enExample) |